wholley

CSRxP Statement On Exclusion Of Big Pharma Accountability Amendment In Appropriations Bill

House Misses Bipartisan Opportunity To Hold Big Pharma Accountable, Increase Transparency For Patients Campaign for Sustainable Rx Pricing Communications Director Lauren Blair issued the following statement […]

Read more

SECOND OPINION: Big Pharma Continues Pointing Fingers for Excessive Drug Prices

Apparently, when it comes to out-of-control drug prices, everyone’s to blame but drug makers themselves, who are solely responsible for setting the list prices of the […]

Read more

Second Opinion: The Real Source of Rising Drug Prices

Big Pharma is always eager to play the blame game – attempting to divert attention away from tactics that price-gouge vulnerable patients. But these gratuitous attacks […]

Read more

CSRxP Urges House Members To Maintain Transparency Provision In Senate-Passed Appropriations Bill

CSRxP-Supported Policy Enables HHS To Require Drug Price Disclosure In Direct-To-Consumer Advertising Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) sent a letter urging […]

Read more